France · Delayed Price · Currency is EUR UV Germi Statistics
Total Valuation
UV Germi has a market cap or net worth of EUR 7.44 million. The enterprise value is 2.84 million.
| Market Cap | 7.44M |
| Enterprise Value | 2.84M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UV Germi has 3.21 million shares outstanding.
| Current Share Class | 3.21M |
| Shares Outstanding | 3.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 27.68% |
| Owned by Institutions (%) | 1.03% |
| Float | 2.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.04 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.57 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.72, with an EV/FCF ratio of 3.27.
| EV / Earnings | n/a |
| EV / Sales | 0.40 |
| EV / EBITDA | 9.72 |
| EV / EBIT | n/a |
| EV / FCF | 3.27 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.74% |
| Revenue Per Employee | 183,477 |
| Profits Per Employee | -1,505 |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -70,282 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.89% in the last 52 weeks. The beta is 0.45, so UV Germi's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -21.89% |
| 50-Day Moving Average | 2.47 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 40.57 |
| Average Volume (20 Days) | 2,277 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UV Germi had revenue of EUR 7.16 million and -58,692 in losses.
| Revenue | 7.16M |
| Gross Profit | 3.22M |
| Operating Income | -102,713 |
| Pretax Income | -128,974 |
| Net Income | -58,692 |
| EBITDA | 292,220 |
| EBIT | -102,713 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | 414,889 |
| Depreciation & Amortization | 394,933 |
| Net Borrowing | n/a |
| Free Cash Flow | 868,469 |
| FCF Per Share | 0.27 |
Margins
Gross margin is 44.95%, with operating and profit margins of -1.44% and -0.82%.
| Gross Margin | 44.95% |
| Operating Margin | -1.44% |
| Pretax Margin | -1.80% |
| Profit Margin | -0.82% |
| EBITDA Margin | 4.08% |
| EBIT Margin | -1.44% |
| FCF Margin | 12.44% |
Dividends & Yields
UV Germi does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.79% |
| FCF Yield | 11.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |